Murray David Esler
#92,613
Most Influential Person Now
Murray David Esler's AcademicInfluence.com Rankings
Murray David Eslerphilosophy Degrees
Philosophy
#3425
World Rank
#5546
Historical Rank
Logic
#1152
World Rank
#1827
Historical Rank

Download Badge
Philosophy
Why Is Murray David Esler Influential?
(Suggest an Edit or Addition)Murray David Esler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (2010) (2086)
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study (2009) (1613)
- Renal sympathetic-nerve ablation for uncontrolled hypertension. (2009) (754)
- Adverse consequences of high sympathetic nervous activity in the failing human heart. (1995) (661)
- Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. (1988) (638)
- Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study (2011) (582)
- Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (2014) (577)
- “Stress” and coronary heart disease: psychosocial risk factors (2003) (573)
- Mild high-renin essential hypertension. Neurogenic human hypertension? (1977) (542)
- Effect of sunlight and season on serotonin turnover in the brain (2002) (491)
- Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. (2015) (477)
- Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation (2004) (455)
- How to assess sympathetic activity in humans. (1999) (442)
- Cardiac sympathetic nerve function in congestive heart failure. (1996) (439)
- The human sympathetic nervous system: its relevance in hypertension and heart failure. (2012) (436)
- The sympathetic system and hypertension. (2000) (428)
- Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial (2012) (426)
- Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy (2003) (421)
- Heart Rate Spectral Analysis, Cardiac Norepinephrine Spillover, and Muscle Sympathetic Nerve Activity During Human Sympathetic Nervous Activation and Failure (1994) (415)
- Sympathetic activation in chronic renal failure. (2009) (406)
- Mechanisms of sympathetic activation in obesity-related hypertension. (2006) (401)
- Translational medicine: the antihypertensive effect of renal denervation. (2010) (397)
- Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. (1991) (396)
- The sympathetic nervous system alterations in human hypertension. (2015) (393)
- The sympathetic nervous system and the metabolic syndrome. (2007) (369)
- Neural mechanisms in human obesity-related hypertension. (1999) (367)
- Human ageing and the sympathoadrenal system (2000) (365)
- Renal denervation in moderate to severe CKD. (2012) (360)
- Determination of norepinephrine apparent release rate and clearance in humans. (1979) (357)
- The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. (1986) (331)
- Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension (2013) (327)
- EFFECT OF CHANGING LEVELS OF PHYSICAL ACTIVITY ON BLOOD-PRESSURE AND HAEMODYNAMICS IN ESSENTIAL HYPERTENSION (1986) (312)
- Sympathetic nervous system and insulin resistance: from obesity to diabetes. (2001) (309)
- Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial (2012) (306)
- Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. (1997) (302)
- Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. (1994) (298)
- Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. (1992) (294)
- Autonomic nervous cardiovascular regulation in borderline hypertension. (1975) (294)
- Measurement of total and organ-specific norepinephrine kinetics in humans. (1984) (293)
- Adrenergic nervous system in heart failure. (1997) (289)
- Interactions Between Leptin and the Human Sympathetic Nervous System (2003) (276)
- Sympathetic Activity in Major Depressive Disorder: Identifying Those at Increased Cardiac Risk? (2007) (266)
- Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension (2013) (257)
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? (2020) (252)
- Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. (2009) (241)
- The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. (2010) (240)
- Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. (2001) (230)
- Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. (2014) (230)
- Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. (1999) (230)
- Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake (1993) (230)
- Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. (2005) (225)
- Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. (2000) (219)
- Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome (2011) (206)
- Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. (2001) (204)
- Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. (2008) (200)
- Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. (1998) (200)
- Noradrenaline turnover during under- and over-eating in normal weight subjects. (1982) (196)
- Exercise Training Lowers Resting Renal But Not Cardiac Sympathetic Activity in Humans (1991) (195)
- The peripheral kinetics of norepinephrine in depressive illness. (1982) (195)
- Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults (2010) (193)
- Dysautonomias: Clinical Disorders of the Autonomic Nervous System (2002) (191)
- Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. (1982) (190)
- Losartan Increases Bradykinin Levels in Hypertensive Humans (2005) (187)
- Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension (2007) (182)
- In vivo measurement of neuronal uptake of norepinephrine in the human heart. (1988) (182)
- Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics (2016) (173)
- Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. (1995) (172)
- Age-dependence of noradrenaline kinetics in normal subjects. (1981) (170)
- Noradrenaline release and sympathetic nervous system activity. (1985) (165)
- Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. (1993) (158)
- Levels of anxiety in colonic disorders. (1973) (158)
- Leptin is released from the human brain: influence of adiposity and gender. (1999) (155)
- CHRONIC MENTAL STRESS IS A CAUSE OF ESSENTIAL HYPERTENSION: PRESENCE OF BIOLOGICAL MARKERS OF STRESS (2008) (154)
- Aging effects on human sympathetic neuronal function. (1995) (153)
- Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. (2003) (152)
- Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. (2011) (150)
- Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity (2003) (148)
- Renal denervation: a potential new treatment modality for polycystic ovary syndrome? (2011) (148)
- Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System (2011) (145)
- Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. (2013) (145)
- Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. (2003) (144)
- Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. (2012) (143)
- Altered Cardiac Responsiveness and Regulation in the Normal Cardiac Output Type of Borderline Hypertension (1975) (141)
- Sympathetic Nerve Biology In Essential Hypertension (2001) (139)
- Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. (2014) (139)
- Norepinephrine Kinetics in Essential Hypertension (1981) (139)
- International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
- New drugs, procedures, and devices for hypertension (2012) (137)
- Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. (1991) (136)
- Sustained Sympathetic and Blood Pressure Reduction 1 Year After Renal Denervation in Patients With Resistant Hypertension (2014) (133)
- Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine (1992) (131)
- Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. (1990) (131)
- Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure (2001) (131)
- Contribution of individual organs to total noradrenaline release in humans. (1984) (130)
- Reduced myocardial nerve growth factor expression in human and experimental heart failure. (2000) (125)
- Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry (2016) (125)
- Gender differences in sympathetic nervous activity: influence of body mass and blood pressure (2007) (122)
- The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension (2011) (120)
- Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. (2010) (119)
- Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. (1995) (119)
- Hydrocortisone‐Induced Hypertension in Humans: Pressor Responsiveness and Sympathetic Function (1989) (117)
- Mediators of sympathetic activation in metabolic syndrome obesity (2008) (116)
- Psychophysiological Mechanisms in Panic Disorder: A Correlative Analysis of Noradrenaline Spillover, Neuronal Noradrenaline Reuptake, Power Spectral Analysis of Heart Rate Variability, and Psychological Variables (2006) (115)
- Increased suicide rate in the middle-aged and its association with hours of sunlight. (2003) (114)
- Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. (1993) (111)
- Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects (2009) (111)
- Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension (1993) (111)
- SUPPRESSION OF SYMPATHETIC NERVOUS FUNCTION IN LOW-RENIN ESSENTIAL HYPERTENSION (1976) (110)
- Sympathetic neuronal regulation of the heart in aging and heart failure. (2005) (109)
- Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings. (2014) (109)
- Exercise and aging: autonomic control of the circulation. (1994) (108)
- Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. (1992) (105)
- Biochemical evidence of sympathetic hyperactivity in human hypertension. (1991) (104)
- Measurement of Sympathetic Nervous System Activity in Heart Failure: The Role of Norepinephrine Kinetics (2000) (102)
- Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. (1997) (102)
- Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. (2009) (102)
- Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes (2002) (101)
- Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge (1989) (101)
- Mental stress and human cardiovascular disease (2017) (101)
- The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? (2019) (100)
- Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. (2005) (99)
- The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. (2002) (98)
- Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. (1973) (98)
- Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. (1991) (97)
- The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. (2011) (97)
- Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension (2000) (95)
- Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure (2010) (94)
- Effect of norepinephrine uptake blockers on norepinephrine kinetics (1981) (94)
- Leptin in human plasma is derived in part from the brain, and cleared by the kidneys (1998) (92)
- Regional sympathetic nervous activation after a large meal in humans. (1995) (91)
- The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? (2001) (90)
- The role of sympathetic nervous activity in renal injury and end-stage renal disease (2010) (90)
- Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation (2004) (89)
- Sympathetic Nervous System: Contribution to Human Hypertension and Related Cardiovascular Diseases (1995) (86)
- Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. (1995) (86)
- Health-Related Quality of Life After Renal Denervation in Patients With Treatment-Resistant Hypertension (2012) (86)
- Evidence for increased renal norepinephrine overflow during sodium restriction in humans. (1990) (84)
- Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. (1999) (84)
- Relation of renin status to neurogenic vascular resistance in borderline hypertension. (1975) (83)
- Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. (2010) (82)
- Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk (2007) (81)
- Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. (1993) (81)
- SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS (1986) (81)
- Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans (2009) (80)
- Altered Sympathetic Nervous Reactivity and Norepinephrine Transporter Expression in Patients With Postural Tachycardia Syndrome (2008) (78)
- Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. (1993) (78)
- Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. (2006) (78)
- Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. (1998) (78)
- Increased norepinephrine spillover into the jugular veins in essential hypertension. (1992) (78)
- Persistence of muscle sympathetic nerve activity during vasovagal syncope. (2010) (77)
- Renal nerve ablation reduces augmentation index in patients with resistant hypertension (2013) (77)
- Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. (2001) (76)
- Effects of Renal Denervation on Sympathetic Activation, Blood Pressure, and Glucose Metabolism in Patients with Resistant Hypertension (2012) (76)
- Sympatholytic action of intravenous amiodarone in the rat heart. (1995) (76)
- Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. (2009) (76)
- Plasma noradrenaline kinetics in humans. (1984) (76)
- Plasma Norepinephrine Responses to Head‐Up Tilt Are Misleading in Autonomic Failure (1992) (75)
- Role of the autonomic nervous system in mild human hypertension. (1975) (75)
- Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure (2012) (75)
- The neuronal noradrenaline transporter, anxiety and cardiovascular disease (2006) (75)
- QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. (2008) (73)
- The ‘adrenaline hypothesis’ of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension (2000) (72)
- Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol (1977) (72)
- Autonomic Control of the Aging Heart (2008) (72)
- Elevated total body noradrenaline spillover in normotensive members of hypertensive families. (1993) (70)
- Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. (2004) (70)
- Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? (2014) (70)
- Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. (1981) (69)
- Human Sympathetic Nerve Biology (2008) (69)
- The neurobiology of human obesity (2005) (69)
- Ghrelin Modulates Sympathetic Nervous System Activity and Stress Response in Lean and Overweight Men (2011) (69)
- Total and renal sympathetic nervous system activity in alcoholic cirrhosis. (1985) (68)
- Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. (1973) (68)
- Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS) (2014) (67)
- Neuroadrenergic Dysfunction Along the Diabetes Continuum (2012) (65)
- β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure (2001) (64)
- Renal denervation and hypertension. (2011) (64)
- Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. (1976) (63)
- Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. (1999) (63)
- Sympathetic responsiveness to head-up tilt in essential hypertension. (1973) (63)
- Sympathetic and cardiac baroreflex function in panic disorder (2002) (62)
- Kinins in humans. (2000) (61)
- Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. (1995) (61)
- Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. (1991) (61)
- Panic disorder: coronary spasm as a basis for cardiac risk? (1998) (61)
- Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. (2013) (61)
- Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. (1998) (61)
- Neuronal Reuptake of Norepinephrine and Production of Dihydroxyphenyiglycol by Cardiac Sympathetic Nerves in the Anesthetized Dog (1991) (60)
- Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. (1998) (60)
- 393 NEUROADRENERGIC DYSFUNCTION ALONG THE DIABETIC CONTINUUM: A COMPARATIVE STUDY IN OBESE METABOLIC SYNDROME SUBJECTS (2012) (60)
- Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering. (2015) (59)
- Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure (2002) (59)
- Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. (1984) (58)
- Blunted norepinephrine responsiveness to changing energy states in obese subjects. (1985) (57)
- Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension (2016) (55)
- Renal denervation for treatment of drug-resistant hypertension. (2015) (55)
- Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor (2007) (55)
- Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. (1997) (55)
- Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men (2013) (54)
- Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep. (1998) (54)
- Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness (2007) (54)
- Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome (2009) (54)
- Recurrent Postural Vasovagal Syncope: Sympathetic Nervous System Phenotypes (2011) (53)
- Leptin-Receptor Polymorphisms Relate to Obesity through Blunted Leptin-Mediated Sympathetic Nerve Activation in a Caucasian Male Population (2008) (53)
- Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review. (2019) (53)
- Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype. (2004) (53)
- Renal Denervation Reduces Monocyte Activation and Monocyte–Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk (2017) (53)
- Treatment of orthostatic hypotension with dihydroergotamine. (1979) (53)
- Single‐unit analysis of sympathetic nervous discharges in patients with panic disorder (2006) (52)
- Regional homovanillic acid production in humans. (1993) (52)
- Cardiac Sympathetic Nerve Biology and Brain Monoamine Turnover in Panic Disorder (2004) (51)
- Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence. (2019) (51)
- Single‐unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover (2011) (51)
- Simultaneous determination of plasma noradrenaline and adrenaline kinetics (1990) (51)
- Low-Dose Estrogen Supplementation Improves Vascular Function in Hypogonadal Men (2001) (50)
- Postprandial sympatho-adrenal activity: its relation to metabolic and cardiovascular events and to changes in meal frequency. (1995) (50)
- Agreement among three different indices of sympathetic nervous system activity in essential hypertension. (1977) (50)
- Direct Evidences for Sympathetic Hyperactivity and Baroreflex Impairment in Tako Tsubo Cardiopathy (2014) (50)
- Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects (2012) (49)
- Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. (1995) (49)
- Determinants of baroreflex sensitivity in man. (1978) (48)
- Low oral bioavailability of dihydroergotamine and first‐pass extraction in patients with Orthostatic hypotension (1981) (48)
- Epigenetic Modification of the Norepinephrine Transporter Gene in Postural Tachycardia Syndrome (2012) (47)
- Differences in the neuronal removal of circulating epinephrine and norepinephrine. (1990) (46)
- Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular Medicine: From Thomas Willis to Resistant Hypertension (2014) (46)
- Effect of renal denervation on kidney function in patients with chronic kidney disease. (2017) (46)
- Postural syncope: mechanisms and management (2007) (46)
- The Sympathetic Nervous System in Hypertension: Back to the Future? (2015) (45)
- Regional 5-hydroxyindoleacetic acid production in humans. (1995) (44)
- European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? (2010) (44)
- The determinants of plasma-renin activity in essential hypertension. (1978) (43)
- Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure. (1990) (42)
- Effects of changes in physical activity on blood pressure and sympathetic tone. (1984) (42)
- Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) (42)
- Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion (2004) (42)
- Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. (1995) (41)
- Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. (1984) (41)
- European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. (2009) (41)
- Simultaneous Characterization of Sympathetic and Cardiac Arms of the Baroreflex through Sequence Techniques during Incremental Head-Up Tilt (2016) (40)
- Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. (2012) (40)
- Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S‐nitrosylation (2000) (40)
- Biochemical quantification of sympathetic nervous activity in humans using radiotracer methodology: fallibility of plasma noradrenaline measurements. (1982) (38)
- LONG-TERM FOLLOW-UP OF CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION CONFIRMS DURABLE BLOOD PRESSURE REDUCTION (2012) (38)
- Immune response to a single bout of exercise in young and elderly subjects (1998) (37)
- Renal denervation for hypertension: observations and predictions of a founder. (2014) (37)
- SINGLE‐UNIT SYMPATHETIC DISCHARGE PATTERN IN PATHOLOGICAL CONDITIONS ASSOCIATED WITH ELEVATED CARDIOVASCULAR RISK (2008) (37)
- Calibrated variability of muscle sympathetic nerve activity during graded head-up tilt in humans and its link with noradrenaline data and cardiovascular rhythms. (2016) (37)
- Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study. (2017) (37)
- Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. (1991) (36)
- Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. (1994) (36)
- A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism (2017) (36)
- Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. (1998) (35)
- Methylation of the SLC6a2 Gene Promoter in Major Depression and Panic Disorder (2013) (35)
- Antiadrenergic effect of chronic amiodarone therapy in human heart failure. (1999) (35)
- Radiotracer methodology for the simultaneous estimation of total, and renal, sympathetic nervous system activity in humans (1982) (35)
- National Heart Foundation of Australia position statement update (2003) (35)
- Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. (2002) (34)
- Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. (1991) (34)
- EFFECT OF PROLONGED TREATMENT ON HÆMODYNAMICS OF ESSENTIAL HYPERTENSION BEFORE AND AFTER AUTONOMIC BLOCK (1980) (34)
- Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure (1991) (33)
- Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. (1998) (33)
- Externally Delivered Focused Ultrasound for Renal Denervation. (2016) (33)
- Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress (2004) (32)
- Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics. (1998) (32)
- Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects. (1997) (31)
- Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. (2013) (31)
- Heart and mind: psychogenic cardiovascular disease. (2009) (31)
- Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. (2007) (31)
- Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension (2012) (31)
- Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. (2014) (30)
- Arterial compliance in hypertension. (1976) (30)
- Effect of practolol on blood pressure and renin release in man (1974) (30)
- Patterns of Catecholamine Excretion in Urine in Hypertension (1970) (30)
- Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. (1995) (29)
- Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. (2013) (29)
- Mental stress is a cause of cardiovascular diseases: from scepticism to certainty (2008) (29)
- Influence of leptin on neurotransmitter overflow from the rat brain in vitro (2002) (29)
- beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. (2001) (28)
- Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension. (1980) (28)
- A Comparative Study in Obese Metabolic Syndrome (2012) (28)
- Fallibility of plasma noradrenaline measurements in studying postprandial sympathetic nervous responses. (1995) (28)
- The autonomic nervous system and cardiac arrhythmias (1992) (26)
- TCT-12 Long-term Follow-up of Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable Blood Pressure Reduction (2012) (26)
- Increased central blood volume: a poosible pathophysiological factor im mild low-renin essential hypertension. (1976) (26)
- Neural mechanisms and management of obesity-related hypertension (2008) (25)
- Angiotensin II and norepinephrine release: interaction and effects on the heart (2005) (25)
- Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea) (2016) (25)
- Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. (1980) (24)
- NET silencing by let-7i in postural tachycardia syndrome. (2017) (24)
- Sympathetic activation in congestive heart failure: an updated overview (2019) (24)
- Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure (2003) (24)
- Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt (2011) (24)
- Renal denervation: current implications and future perspectives. (2014) (23)
- Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation* (2018) (23)
- Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. (2010) (23)
- The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia (2014) (23)
- Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. (2016) (23)
- Measurement of human sympathetic nervous responses to stressors by microneurography. (1994) (23)
- Selective vs. Global Renal Denervation: a Case for Less Is More (2018) (22)
- Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs (1992) (22)
- The future of renal denervation (2017) (21)
- Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? (2010) (21)
- Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension. (1981) (21)
- Redevelopment of essential hypertension after cessation of long term therapy; preliminary findings. (1984) (21)
- Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. (1991) (21)
- Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension. (2020) (21)
- Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension (1988) (21)
- Mechanisms of Carvedilol Action in Human Congestive Heart Failure (2001) (21)
- The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? (2002) (21)
- Modulation of renal sympathetic innervation: recent insights beyond blood pressure control (2018) (21)
- Catheter-based renal denervation: the next chapter begins. (2018) (20)
- High catecholamine essential hypertension: clinical and physiological characteristics. (1973) (20)
- Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. (1997) (20)
- Norepinephrine Kinetics in Patients with Idiopathic Autonomic Insufficiency (1980) (20)
- Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms. (1998) (20)
- Effects of Moxonidine and Low‐Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies (2017) (19)
- SPRINT, or False Start, Toward a Lower Universal Treated Blood Pressure Target in Hypertension. (2016) (19)
- Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
- NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro (2004) (19)
- Cardiac secretion and renal clearance of atrial natriuretic peptide in normal man: effect of salt restriction. (1989) (19)
- Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. (1998) (19)
- Obesity-Associated Organ Damage and Sympathetic Nervous Activity: A Target for Treatment? (2019) (18)
- Association of vitamin D status and blood pressure response after renal denervation (2013) (18)
- Human muscle sympathetic activity and cardiac catecholamine spillover: no support for augmented sympathetic noradrenaline release by adrenaline co-transmission. (1998) (18)
- Effects of estrogen on stress responses in women. (1999) (18)
- Altered venous responses to vasoconstrictor agonists and nerve stimulation in human primary hypertension. (1990) (18)
- Catecholamines and essential hypertension. (1993) (18)
- Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension (2001) (18)
- Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial (2018) (18)
- Anxiety - bridging the heart/mind divide (2010) (17)
- Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits. (1991) (17)
- MENTAL STRESS, PANIC DISORDER AND THE HEART (1998) (17)
- Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. (1999) (17)
- The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension. (2015) (16)
- Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure. (2003) (16)
- Atrial Fibrillation Is Associated with Decreased Cardiac Sympathetic Response to Isometric Exercise in CHF in Comparison to Sinus Rhythm (2008) (16)
- Increased spillover and reduced clearance both contribute to rise in plasma catecholamines after birth in lambs. (1996) (16)
- The nervous system in arterial hypertension : [proceedings] (1976) (16)
- Total body catecholamine kinetics before and after birth in spontaneously hypoxemic fetal lambs. (1999) (16)
- Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits (1990) (16)
- Last Word on Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension (2010) (16)
- High-renin essential hypertension: adrenergic cardiovascular correlates. (1976) (16)
- The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes. (1987) (16)
- Is essential hypertension sometimes a psychosomatic disorder? (2004) (16)
- Renal denervation: Not as easy as it looks (2015) (15)
- A polymorphism in the noradrenaline transporter gene is associated with increased blood pressure in patients with resistant hypertension (2017) (15)
- Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. (1995) (15)
- Assessing the strength of cardiac and sympathetic baroreflex controls via transfer entropy during orthostatic challenge (2017) (15)
- New Drugs and Technologies Device-Based Antihypertensive Therapy Therapeutic Modulation of the Autonomic Nervous System (2011) (15)
- Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure. (2005) (15)
- Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor? (2002) (14)
- Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial (2022) (14)
- Blood pressure and sympathetic nervous system response to renal denervation. (2013) (14)
- How hypertension redevelops after cessation of long-term therapy. (1984) (14)
- TCT-61 Optimized External Focused Ultrasound for Renal Sympathetic Denervation - Wave II trial (2013) (14)
- Renal catecholamine metabolism. (1989) (14)
- Pulmonary clearance and release of norepinephrine and epinephrine in newborn lambs. (1997) (14)
- Role of Ca2+ in metabolic inhibition-induced norepinephrine release in rat brain synaptosomes. (1997) (13)
- The failing human heart does not release nitrogen oxides. (1998) (13)
- The relation of human cardiac sympathetic nervous activity to left ventricular mass: commentary. (1996) (13)
- Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. (1992) (13)
- Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension. (1977) (13)
- Characterization of the Asymmetry of the Cardiac and Sympathetic Arms of the Baroreflex From Spontaneous Variability During Incremental Head-Up Tilt (2019) (13)
- The Sympathetic Nervous System in Cirrhosis (2007) (13)
- Successful Renal Denervation Decreases the Platelet Activation Status in Hypertensive Patients. (2019) (13)
- Greater sympathoadrenal activation with longer preventilation intervals after immediate cord clamping increases hemodynamic lability at birth in preterm lambs. (2017) (13)
- Potential role of endurance training in altering renal sympathetic nerve activity in CKD? (2017) (13)
- Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover (1999) (13)
- Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? (2006) (13)
- ASSESSMENT OF NEURONAL UPTAKE OF NORADRENALINE IN HUMANS: DEFECTIVE UPTAKE IN SOME PATIENTS WITH ESSENTIAL HYPERTENSION (1980) (12)
- TWO-YEAR DURABILITY OF BLOOD PRESSURE REDUCTION WITH CATHETER-BASED RENAL SYMPATHETIC DENERVATION: HT.3.04 (2010) (12)
- Aromatase inhibition alters vascular reactivity and arterial compliance in men: a possible vascular role for endogenous sex hormones in males. (1999) (12)
- ADRENALINE RELEASE BY THE HUMAN HEART (1991) (12)
- Effects of weight loss on renal function in overweight Japanese men (2011) (12)
- CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE. (2021) (12)
- Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep. (1998) (12)
- Mineralocorticoid induced hypertension and noradrenaline spillover in man. (1994) (11)
- Recent advances in the treatment of hypertension (2011) (11)
- Modulation of vascular function by diet and exercise. (1997) (11)
- Effects of renal denervation on insulin resistance (2012) (11)
- Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment. (2018) (11)
- Catechol‐O‐methyltransferase activity in CHO cells expressing norepinephrine transporter (1999) (11)
- Stress and cardiovascular disease: a report from the National Heart Foundation of Australia (1988) (11)
- Non-invasive evaluation of the cardiac function in Golden Retriever dogs by radionuclide angiography (1993) (11)
- Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes—possible influence of venous anatomy and comorbid major depressive disorder (2007) (11)
- The place of exercise in the long-term treatment of hypertension. (1987) (11)
- Study of noradrenaline uptake and spillover to plasma in normal subjects and patients with essential hypertension. (1980) (11)
- Central Nervous System Norepinephrine Turnover in Essential Hypertension fn1 (1995) (11)
- Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion. (1977) (10)
- Oxygen consumption in the heart, hepatomesenteric bed, and brain in young and elderly human subjects, and accompanying sympathetic nervous activity. (1996) (10)
- The sympathetic regulation of the heart. (2016) (10)
- New Therapeutic Approaches to Resistant Hypertension (2010) (10)
- Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis (1996) (10)
- Health-related quality of life and blood pressure 12 months after renal denervation (2015) (9)
- Is adrenaline released by sympathetic nerves in man? (1991) (9)
- Take a blood pressure pill or undergo renal denervation? (2018) (9)
- Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge. (1995) (9)
- Neurogenic maintenance of peripheral resistance in borderline hypertension. (1974) (9)
- High blood pressure management: potential benefits of I1 agents. (1998) (9)
- Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study (2016) (9)
- Left ventricular norepinephrine and epinephrine kinetics at birth in lambs. (1997) (8)
- The influence of aging on the plasma concentration and renal clearance of homovanillic acid (1994) (8)
- Pathogenesis of human primary hypertension: a new approach to the identification of causal factors and to therapy. (1986) (8)
- DIFFERING NORADRENALINE KINETICS IN ESSENTIAL HYPERTENSION AND DEPRESSIVE ILLNESS, TWO DISEASES IN WHICH THE PLASMA CONCENTRATION OF NORADRENALINE IS SOMETIMES ELEVATED (1981) (8)
- Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies. (2012) (8)
- Epigenomic changes associated with impaired norepinephrine transporter function in postural tachycardia syndrome (2017) (8)
- Depressive illness, the sympathetic nervous system and cardiac risk. (2009) (8)
- Cardiac ablation and renal denervation systems have distinct purposes and different technical requirements. (2013) (8)
- Reduced HRV and baroreflex sensitivity as universally applicable cardiovascular “risk factors”: waiting for the bubble to burst (2003) (7)
- The Effect of Renal Denervation on Plasma Adipokine Profile in Patients with Treatment Resistant Hypertension (2017) (7)
- Effects of Nebivolol on Haemodynamics, Cardiac Dimensions and Function, Cardiovascular Reflexes and Biochemical Measures of Sympathetic Activity in Normal Human Subjects (1991) (7)
- How can we measure sympathetic nervous system "tone" in patients? (1984) (7)
- Relationship between Maximum Chronotropic Response to Isoproterenol in Man and Generation of Cyclic Adenosine Monophosphate by Lymphocytes (1980) (7)
- Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension. (1987) (7)
- Factors influencing the choice of antihypertensive agents. (1976) (7)
- CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation (2014) (7)
- Sympathetic nervous system neuroplasticity. (2006) (7)
- [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion]. (2003) (7)
- Development of the metabolic syndrome along the female biological life-path. (2006) (7)
- On a low calorie diet, are there separate and discrete effects of negative energy balance and weight loss on blood pressure? (2003) (7)
- Consequences of the evolutionary cardiovascular challenge of human bipedalism: orthostatic intolerance syndromes, orthostatic hypertension. (2019) (6)
- Does sympathetic dysfunction occur before denervation in pure autonomic failure? (2018) (6)
- Renal denervation for resistant hypertension—the Symplicity HTN-1 study – Authors' reply (2014) (6)
- Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients (2022) (6)
- Catecholamine levels in tricyclic antidepressant self-poisoning. (1974) (6)
- RATE OF REMOVAL OF NOREPINEPHRINE FROM THE CIRCULATION IN HEALTHY MEN AND PATIENTS WITH ESSENTIAL HYPERTENSION (1979) (6)
- Management of Hypertension Complicated by Psychiatric Comorbidity (2007) (6)
- Letter by Kaye and Esler regarding article "extracardiac progenitor cells repopulate most major cell types in the transplanted human heart". (2006) (6)
- The sympathetic system in essential hypertension. (2000) (6)
- An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure (2004) (6)
- Is very high sympathetic tone in heart failure a result of keeping bad company? (2003) (6)
- Stress, behavior and the heart (2017) (5)
- Renal Denervation After the SPYRAL HTN-OFF MED Trial: Putting a Complex Study Into Context. (2017) (5)
- Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation (2017) (5)
- Predictive factors for successful renal denervation: should we use them in clinical trials? (2017) (5)
- Effect of 1 year's therapy in essential hypertension on systemic haemodynamics studied before and after 'total' autonomic blockade. (1979) (5)
- Impaired pancreatic polypeptide release to insulin hypoglycaemia in chronic autonomic failure with postural hypotension: evidence for parasympathetic dysfunction. (1982) (5)
- Mental stress and human cardiovascular disease (2015) (5)
- Acute mental stress responses : neural mechanisms of adverse cardiac consequences (2008) (5)
- Sympathotonia in primary hypertension and in a caricature resembling dysautonomia. (1976) (5)
- Does increased 24-h ambulatory heart rate identify de facto neurogenic hypertension, and facilitate selection of hypertensive patients for renal denervation? (2019) (5)
- REDUCED BLOOD PRESSURE LOWERING EFFECT OF CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: DATA FROM POOLED SYMPLICITY HTN TRIALS (2015) (5)
- TCT-58 Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial (2013) (5)
- [Sympathetic nerve activity in essential hypertension. New pathophysiologic aspects]. (2003) (4)
- EFFICACY AND CLINICAL AND ECONOMIC EFFECTIVENESS IN RESISTANT HYPERTENSIVE SUBGROUPS (2012) (4)
- Plasma lipocalin-2/NGAL is stable over 12 weeks and is not modulated by exercise or dieting (2021) (4)
- Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. (2022) (4)
- Sympathetic Activation in Essential Hypertension: Understanding the Toxic Trifecta. (2018) (4)
- Central nervous system norepinephrine turnover in essential hypertension. (1995) (4)
- Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer (2002) (4)
- Central and peripheral norepinephrine kinetics in heart failure, coronary artery disease, and hypertension. (1998) (4)
- Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs. (1999) (4)
- Abnormalities of the Autonomic Nervous System in Heart Failure: Assessment, Potential Mechanisms, and Implications (1995) (3)
- ESSENTIAL HYPERTENSION WITH SYMPTOMS OF HYPERKINETIC CIRCULATION (1973) (3)
- Renal artery denervation via catheter-based delivery of low-power radiofrequency energy provides safe and durable blood pressure reduction: complete 3 year results from SYMPLICITY HTN-1 (2013) (3)
- A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension. (1987) (3)
- The Role of Cardiovascular Hypertrophy in Hypertension: Basis for a New Therapeutic Strategy (1987) (3)
- Differential sympathetic response to lesion-induced chronic kidney disease in rabbits. (2020) (3)
- Presynaptic antisympathetic action of amiodarone and its metabolite desethylamiodarone. (1999) (3)
- Treatment of essential hypertension. (1979) (3)
- EFFECT OF A SINGLE BOUT OF EXERCISE ON IMMUNE FUNCTION IN YOUNG AND ELDERLY SUBJECTS 555 (1996) (3)
- Effect of endurance exercise on cardiac secretion and renal clearance of atrial natriuretic peptide in normal humans. (1990) (3)
- Autonomic Nervous System: Metabolic Function (2009) (3)
- Renal denervation reduces left ventricular mass in patients with resistant hypertension - results from a multicenter CMR-study (2013) (3)
- Renal sympathetic denervation for refractory hypertension – Author's reply (2011) (2)
- Catecholamine metabolites in internal jugular plasma: a window into the human brain. (1998) (2)
- Methylation of the SLC 6 a 2 Gene Promoter in Major Depression and Panic Disorder (2017) (2)
- Renal nerve ablation for hypertension: Update from an insider. (2018) (2)
- EFFECTS OF INTRACELLULAR Ca2+ CHELATING ON NORADRENALINE RELEASE IN NORMOXIC AND ANOXIC HEARTS (1997) (2)
- Cardiovascular and Autonomic Responses to Stress (2011) (2)
- 311 FEASIBILITY OF CATHETER-BASED RENAL DENERVATION AND EFFECTS ON SYMPATHETIC NERVE ACTIVITY AND BLOOD PRESSURE IN PATIENTS WITH END-STAGE RENAL DISEASE (2012) (2)
- Dissociation of the renin lowering and antihypertensive actions of propranolol. (1976) (2)
- Response to quality of life after renal denervation. (2013) (2)
- Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study. (1986) (2)
- Abstract 816: Sympathetic Nerve Protein Analysis, Sympathetic Microneurography and Catecholamine Kinetics in Postural Syncope Phenotypes (2007) (2)
- Patterns of neurogenic involvement in borderline and essential hypertension. (1977) (2)
- OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION (2016) (2)
- Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified (2022) (2)
- Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension". (2014) (2)
- EVIDENCE FOR A ROLE FOR THE CARDIOVASCULAR AMPLIFIERS IN HUMAN PRIMARY HYPERTENSION (1991) (2)
- Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension". (2007) (2)
- Sympathomodulation in congestive heart failure: From drugs to devices. (2020) (2)
- Pseudopheochromocytoma. (2019) (2)
- Effects of Dietary Sodium Intake on Indices of Sympathetic Activity in Normal Man (1980) (2)
- SUSTAINED REDUCTION OF CENTRAL SYMPATHETIC OUTFLOW AFTER RENAL DENERVATION IN END STAGE RENAL DISEASE: 7B.10 (2011) (2)
- Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. (2016) (2)
- Results from a multicenter CMR-study in patients with resistant hypertension - pre and post renal denervation (2013) (2)
- Cardiovascular trophic effects from the sympathetic nerve cotransmitter neuropeptide Y in end-stage renal disease? (2003) (2)
- 787 EFFECTS OF TRANSCATHETER RENAL NERVE ABLATION ON SYMPATHETIC AND NEUROHORMONAL ACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION (2012) (2)
- Pivotal role of the sympathetic nerves of the human heart in mental stress responses and triggered cardiovascular catastrophes (2021) (2)
- Neurochemical quantification of human organ-specific sympathetic nervous system activity. (2000) (2)
- Harnessing the Autonomic Nervous System for Therapeutic Intervention (2012) (2)
- Sympathetic Neurobiology of Orthostatic Intolerance: A systematic Biochemical and Molecular Analysis of Patients with Vasovagal Syncope, Low Supine Systolic Blood Pressure and Postural Tachycardia Syndrome (2008) (2)
- Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome. (2020) (2)
- The adrenal medulla in cardiovascular medicine: an untold story (2020) (2)
- PREDICTORS OF BLOOD PRESSURE RESPONSE FOLLOWING CATHETER RENAL DENERVATION: A POOLED ANALYSIS OF THE SYMPLICITY HTN-1AND HTN-2 TRIALS (2013) (1)
- Expression of leptin and leptin receptor isoforms in human myocardium: A role in cardiac function and the pathophysiology of CHF? (2000) (1)
- Abstract 18179: Catheter-Based Renal Denervation Reduces Left Ventricular Mass in Patients with Resistant Hypertension - Results from a Multicenter Study (2012) (1)
- Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder (2022) (1)
- ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. (2016) (1)
- Two patients with abnormalities of regional sympathetic nervous tone. (1984) (1)
- Practolol in hypertension: reduction in sympathetic nervous and renin responses. (1973) (1)
- Renal denervation alters ambulatory blood pressure-derived salt sensitivity index in patients with uncontrolled hypertension (2021) (1)
- ANESTHESIOLOGIST INTERVENTION RATE AND EFFICACY OF PARTURIENT‐CONTROLLED EPIDURAL ANALGESIA (PCEA) ‐ EFFECT OF INCREASING CONCENTRATION OF BOLUS SOLUTION USING 0.0625% BUPIVACAINE + 0.0002% FENTANYL BACKGROUND INFUSION: P‐59 (2002) (1)
- Failure Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart (2000) (1)
- [OP.7A.11] CHROMOGRANIN A AS A PREDICTIVE MARKER OF SUCCESSFUL RENAL DENERVATION (2017) (1)
- Activity of the sympathetic nervous system and renin-angiotensin system in essential hypertension (1972) (1)
- Assessing Correlation between Heart Rate Variability Markers Based on Laguerre Expansion and Direct Measures of Sympathetic Activity during Incremental Head-up Tilt (2021) (1)
- CRT-608 Pooled 3-Year Symplicity Htn-1 and Symplicity Htn-2 Results and Diabetes Subgroup Analysis (2014) (1)
- Clinical Studies of the Sympathetic Nervous System (2002) (1)
- Estrogen supplementation decreases total body norepinephrine spillover in perimenopausal women (1996) (1)
- Relationship of renin status to adrenergic vascular tone in borderline hypertension (1974) (1)
- Reply: Platelet noradrenaline uptake is unrelated to renal denervation (2016) (1)
- Response by Grassi et al to Letter Regarding Article, "The Sympathetic Nervous System Alterations in Human Hypertension". (2016) (1)
- Reply: Possible impact of membrane ACE2 expression on COVID-19 infection. (2020) (1)
- Response to Letter Regarding Article, “Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study” (2011) (1)
- Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity (2016) (1)
- Potentiated Blood Pressure Response to Renal Nerve Ablation in Patients with Resistant Hypertension Treated with the Centrally Acting Sympatholytic Agent Moxonidine (2013) (1)
- Wednesday, May 16, 4:00 PM to 6:00 PM Sympathetic Nervous System, I1 Imidazoline Receptors, Hypertension and Metabolic Disorders*: Sympathetic nervous system and insulin resistance: From obesity to diabetes* (2001) (1)
- Droxidopa improves orthostatic intolerance symptoms in low and normal supine blood pressure phenotypes of vasovagal syncope (2015) (1)
- [PP.05.32] PROFOUND SYMPATHETIC NERVOUS SYSTEM ACTIVATION IN PATIENTS WTH RESISTANT HYPERTENSION (2017) (1)
- Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?". (2014) (1)
- Psychological Stress and the Development of Heart Disease (2007) (1)
- The sympathetic nervous system through the ages: From Thomas Willis to resistant hypertension - The Physiological Society 2010 Paton Prize Lecture (2010) (1)
- Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches (2021) (1)
- The Causal Role of Chronic Mental Stress in the Pathogenesis of Essential Hypertension (2011) (1)
- Neurovascular Role of Sympathetic Nervous System and Beta-Adrenoceptor Polymorphisms in Obesity and Hypertension (2008) (1)
- Renal Denervation for the Hypertension of Chronic Kidney Disease: A Special Case? (2016) (1)
- Sympathetic nervous activity and the thermic effect of food in humans. (1998) (1)
- 106 – Panic Disorder (2004) (1)
- Chapter 126 – Panic Disorder (2012) (1)
- Catheter based radiofrequency ablation of renal nerves for the treatment of resistant hypertension (2012) (1)
- OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. (2016) (1)
- RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF DRUG-RESISTANT HYPERTENSION IN AN ASIAN POPULATION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY IN SOUTH KOREA (GSR KOREA) AND COMPARISON TO SYMPLICITY HTN-2 (2015) (0)
- An evaluation of expectancy bias in interoceptive accuracy research (2006) (0)
- A-33 | Clinical Event Reductions in Younger Vs. OLDER Hypertension Patients treated with Radiofrequency Renal Denervation: 10-Year Projections based on 3-Year Follow-up from the Global SYMPLICITY Registry (2022) (0)
- The left vent ‘amplifier’ in hypertension (1986) (0)
- A2589 Testing for achieved renal denervation in resistant hypertension patients by measuring passage of tyrosine hydroxylase from degraded sympathetic nerves to urine: Preliminary observations (2018) (0)
- Reflections on the past four decades of mental stress research in autonomic cardiology (2021) (0)
- EXOGENOUS BRAIN NATRIURETIC PEPTIDE INHIBITS REFLEX SYSTEMIC AND REGIONAL SYMPATHETIC STIMULATION IN HEALTHY HUMANS: P2.177 (2000) (0)
- nervous activation in human obesity? Is obstructive sleep apnea the cause of sympathetic (2013) (0)
- ELEVATED SYMPATHETIC NERVOUS ACTIVITY IS RELATED TO THE DEVELOPMENT OF RENAL INJURY IN PATIENTS WITH DIABETES AND/OR HYPERTENSION: PP.30.189 (2010) (0)
- PP.40.06: RENAL ARTERY ANATOMY AFFECTS THE BLOOD PRESSURE RESPONSE TO RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION (2015) (0)
- Atrial fibrillation further impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure (2005) (0)
- Reply to letter to the Editor entitled: Ambulatory arterial stiffness index: a (too) easy predictor for renal denervation success? (2018) (0)
- SIGNIFICANT, LONG–TERM REDUCTIONS IN BLOOD PRESSURE AND PULSE PRESSURE ARE OBSERVED IN BOTH OLDER AND YOUNGER PATIENTS WITH RESISTANT HYPERTENSION FOLLOWING TREATMENT WITH THE SYMPLICITY™ RENAL DENERVATION SYSTEM (2013) (0)
- Panic disorder : sympathetic nervous mechanisms and net gene epigenetics underlying increased cardiac risk (2005) (0)
- Transcatheter Aortic Valve Implantation Reduces Sympathetic Activity and Normalizes Arterial Spontaneous Barore fl ex in Patients With Aortic Stenosis (2013) (0)
- Sympathetic Neural and Adrenal Medullary Mechanisms in Depression and Panic Disorder (2011) (0)
- Rest and Exercise and the Functional Assessment of Patients With Congestive Heart Failure (2005) (0)
- Hearts and minds. (2003) (0)
- Major lung contribution to despiramine - induced changes in whole body noradrenaline and adrenaline kinetics (1998) (0)
- Assessing the Assessment of Brain Serotonin Turnover—Reply (2008) (0)
- CARDIAC NORADRENALINE SPILLOVER IS NOT CORRELATED WITH HRV AND QT VARIABILITY IN PATIENTS WITH DEPRESSION AND PANIC DISORDER (2010) (0)
- Asymmetry Assessment of Cardiac and Sympathetic Arms of the Baroreflex (2018) (0)
- Rebuttal from Markus P. Schlaich, Yusuke Sata and Murray D. Esler (2014) (0)
- CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
- Season as a Possible Confounding Factor in Reduced Brain Serotonin Turnover Following Selective Serotonin Reuptake (2016) (0)
- TCT-215 Effect Of Renal Denervation Therapy On Blood Pressure And Pulse Pressure In Young Compared To Old Patients (2012) (0)
- Are Important Components of Kidney Function Lost With Renal Denervation? (2017) (0)
- Ambulatory blood pressure changes and predictors of response in patients undergoing renal sympathetic denervation (2013) (0)
- Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation. (2008) (0)
- Renal denervation for severe hypertension: Past, present and future (2015) (0)
- Response to four comments on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’ (2020) (0)
- CONTRIBUTION OF SYMPATHETIC NERVOUS SYSTEM ACTIVITY TO OBESITY–INDUCED SUBCLINICAL ORGAN DAMAGE IN YOUNG ADULTS: 9B.07 (2010) (0)
- Cardiac Sympathetic Activity with Ageing and Relationship to Diastolic Function (1997) (0)
- Psychogenic Cardiovascular Disease: Underlying Autonomic Nervous Mechanisms (2007) (0)
- C-002 SYMPATHETIC NERVE PROTEIN ABNORMALITIES IN PATIENTS WITH RECURRENT VASOVAGAL SYNCOPE (2011) (0)
- Ablating the renal nerves to treat heart failure with reduced ejection fraction: another treatment option in a crowded space? (2020) (0)
- HUMAN OBESITY‐RELATED HYPERTENSION: BRAIN NEUROTRANSMITTERS AND REGIONAL NORADRENALINE SPILLOVER (1997) (0)
- Biventricular pacing improves medium term but not acute cardiac adrenergic profile in congestive heart failure (2005) (0)
- OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2016) (0)
- Response: Neural Sympathetic Activity in Essential Hypertension (2004) (0)
- Rebuttal from Esler, Lambert, and Schlaich. (2010) (0)
- Fine tuning renal denervation. (2018) (0)
- submaximal exercise in young and old subjects Norepinephrine spillover at rest and during (2015) (0)
- Comparative effects of T- and L- type calcium channel blockage on autonomic function in patients with mild-moderate hypertension (1999) (0)
- Biochemical investigation of autonomic function—measurement of catecholamines and metabolites, and the use of spillover and allied techniques to determine regional sympathetic activation (2013) (0)
- Effects of intravenous B-type natriuretic peptide (BNP) on regional sympathetic tone in patients with chronic heart failure and healthy controls (2000) (0)
- Reply. (2018) (0)
- Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure (2005) (0)
- Response to more research is needed to investigate the effect of denervation on blood pressure. (2014) (0)
- Left atrial reduction: the forgotten (1998) (0)
- Acknowledgment to Reviewers (2020) (0)
- Major pulmonary contribution to desipramine-induced changes in whole body noradrenaline and adrenaline kinetics in newborn lambs (1997) (0)
- Abstract 14741: Ambulatory Arterial Stiffness Index Predicts Responder of Renal Denervation (2016) (0)
- Sympathetic nerve activity and left ventricular hypertrophy in human hypertension (2007) (0)
- 385 EFFECT OF RENAL NERVE ABLATION ON ARTERIAL STIFFNESS IN RESISTANT HYPERTENSION (2012) (0)
- Harnessing the Autonomic System for Therapeutic Intervention (2014) (0)
- Hypertension 1 New drugs, procedures, and devices for hypertension (2012) (0)
- Predictors of Blood Pressure Response Following Catheter Renal Denervation: A Pooled Analysis of the Symplicity HTN-1 and HTN-2 Trials (2013) (0)
- Workshop : epidemiology and classification of hypertension (1991) (0)
- Workshop Epidemiology and Classification of Hypertension: Participants (1991) (0)
- Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs. (1999) (0)
- ACE2 DOES NOT PLAY A MAJOR ROLE IN ANGIOTENSIN PEPTIDE METABOLISM IN THE HUMAN CORONARY CIRCULATIO: 6C.1 (2004) (0)
- Cardiac Psychology: Ancient and Modern History (2015) (0)
- MO085: 10-Year Clinical Events Avoided in Diabetic and Chronic Kidney Disease Hypertension Patients Treated With Radiofrequency Renal Denervation: Projections Based on 3-Year Data From the Global Symplicity Registry (2022) (0)
- Controlling Blood Pressure without Drugs - Developing New Strategies Hypertension (2010) (0)
- contributor to systemic hypertension sympathetic nervous system is the dominant Last Word on Point: Chronic activation of the (2015) (0)
- Increased catecholamine spillover accounts for elevated circulating norodrenaline and adrenaline levels (1998) (0)
- THE OVERLAPPING MECHANISM OF WEIGHT LOSS RESISTANCE AND REBOUND FROM A SIGNIFICANT WEIGHT LOSS IN OBESE SUBJECTS: P1.240 (2004) (0)
- 788 PROFOUND REDUCTION IN SYMPATEHTIC NERVE FIRING PATTERN AFTER RENAL DENERVATION IN RESISTANT HYPERTENSION (2012) (0)
- Baroreflex sensitivity: a reliable predictor of response to renal denervation? (2014) (0)
- Gender differences in added benefit of catheter-based renal denervation for resistant hypertension: model-based estimation of unadjusted and quality-adjusted life year gains in males and females (2013) (0)
- Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension: Impact Of Age And Cardiovascular Risk Factors. (2014) (0)
- Evidence for the role of peripheral α-2 receptors in reducing noradrenaline release (2000) (0)
- Results from Symplicity HTN-2 (2010) (0)
- ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. (2016) (0)
- PP.12.09: NEURAL BIOLOGY OF PURE AUTONOMIC FAILURE (2015) (0)
- Acute Electrophysiologic Effects of Intravenous Amiodarone Are Independent of a Sympatholytic Action in Humans (2003) (0)
- Renal Denervation Prevents Progression of Hypertension by Reversing Baroreflex Resetting in a Rabbit Model of Chronic Kidney Disease (2017) (0)
- [OP.7D.10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION (2016) (0)
- Sympathetic Nerve Protein Analysis: A Novel Window into Sympathetic Nervous System Dysfunction (2010) (0)
- Pharmacological Treatments for Obesity (2010) (0)
- Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed double-spaced) in length and may be subject to editing or abridgment. (2013) (0)
- The synergistic relationship between atrial fibrillation and heart failure (2002) (0)
- Marked suppression of the tissue kallikrein-kinin-system in cardiac failure (2000) (0)
- EVIDENCE FOR REDUCED MYOCARDIAL SYMPATHETIC INNERVATION IN HUMAN ESSENTIAL HYPERTENSION: 3C.2 (2004) (0)
- Panic Disorder: Epigenetic Silencing of the Noradrenaline Transporter (NET) Gene Contributes Both to Causation and to Heart Risk (2007) (0)
- Sympatho-Modulation by Renal Denervation in Spontaneously Hypertensive Rats (2013) (0)
- Differential effects of T- & L-type calcium channel blockade on autonomic function in patients with mild-moderate essential hypertension (2000) (0)
- Assessing the Assessment of Brain Serotonin Turnover. Authors' reply (2008) (0)
- 0754 International Session Role of Calcium in Energy Depletion-Induced Norepinephrine(NE)Release-Studies on Perfused Heart and Incubated Synaptosome (1996) (0)
- A SELECTIVE UPREGULATION OF GABAA RECEPTOR SUBUNIT EXPRESSION IS ASSOCIATED WITH THE HYPOTENSIVE EFFECTS OF GANAXOLONE IN MALE HYPERTENSIVE SCHLAGER MICE (2021) (0)
- Device-based approaches to target renal sympathetic nerves for hypertension (2016) (0)
- Effects of continuous positive airway pressure (CPAP) on haemodynamics and sympathetic nervous activity in heart failure (2000) (0)
- Schlaich, M. P. (2019). Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of- (2019) (0)
- CENTRAL NERVOUS SYSTEM MONOAMINE NEUROTRANSMITTER HYPERTENSION TURNOVER IN PRIMARY AND OBESITY-RELATED HUMAN (1997) (0)
- Abstract 3559: {beta}2-adrenoceptor Protein Expression Is Different Between Buffy Coat And Adipose Tissue (2007) (0)
- Central and Peripheral Norepinephrine Secretion in Major Depression is Activated, as Assessed by 24 hour CSF and Plasma Sampling (2014) (0)
- Dissociation between changes in whole body noradrenaline and adrenaline spillovers at birth in hypoxaemic fetal lambs (1998) (0)
- Role of the Sympathetic Nervous System in Cardiovascular Disease (2016) (0)
- In conclusion, total norepinephrine spillover data must be interpreted very cautiously. (1988) (0)
- Esler and Michael Böhm MurrayC (2011) (0)
- 60 Release of adrenaline by human sympathetic nerves: studies in healthy subjects and patients with essential hypertension (1993) (0)
- CATHETER-BASED RENAL DENERVATION – LONG TERM SAFETY AND BLOOD PRESSURE REDUCTION IN PATIENTS WITH RESISTANT HYPERTENSION (2022) (0)
- OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. (2016) (0)
- 1088 A SHORT HISTORY OF THE SYMPATHETIC NERVOUS SYSTEM: FROM THOMAS WILLIS TO RADIOFREQUENCY ABLATION OF THE RENAL SYMPATHETIC NERVES IN HYPERTENSION (2012) (0)
- Renal Denervation for Refractory Hypertension (2011) (0)
- RENAL DENERVATION REDUCES CENTRAL SYMPATHETIC DRIVE AND IMPROVES INSULIN SENSITIVITY IN PCOS: PP.26.311 (2011) (0)
- Should an Alerting Response and Blood Pressure Measurement Never Be Mixed? (2021) (0)
- TCT-731 TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) REDUCES SYMPATHETIC ACTIVITY AND NORMALIZES ARTERIAL SPONTANEOUS BAROREFLEX IN PATIENTS WITH AORTIC STENOSIS (2013) (0)
- Is “cardiovascular protection” by estrogens due to inhibition of the sympathetic nervous system? (2005) (0)
- Arterial hypertension. Pathogenesis, diagnosis and therapy (1984) (0)
- 2. Renal denervation in 2014: “Has a beautiful idea been ruined by cold, hard facts?” (2014) (0)
- EFFECTOFPROPRANOLOL ON NORADRENALINEKINETICS INPATIENTSWITHESSENTIALHYPERTENSION (1981) (0)
- Percutaneous renal sympathetic denervation for treatment of resistant hypertension (2009) (0)
- PM256 Effects of Catheter-based Renal Sympathetic Denervation on Blood Pressure Variability and Morning Surge of BP in Resistant Hypertensive Patients (2014) (0)
- CRT-600.06 Cost-Effectiveness of Catheter-Based Radiofrequency Renal Denervation for the Treatment of Uncontrolled Hypertension: An Analysis for the UK Based on Recent Clinical Evidence (2023) (0)
- B-type natriuretic peptide (BNP), but not atrial natriuretic peptide (ANP), improves haemodynamics in acute heart failure (2000) (0)
- Comparison of Patients With Congestive Heart Failure and Normal Subjects (2005) (0)
- THE EFFECT OF CENTRAL LEPTIN ADMINISTRATION ON CARDIOVASCULAR RESPONSES IN CONSCIOUS RABBITS FED A HIGH-FAT DIET: 8B.3 (2004) (0)
- Total body catecholamine kinetics before and after birth in spontaneously hypoxemic fetal lambs. (1999) (0)
- CARDIORESPIRATORY RESPONSE TO EXERCISE AFTER RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: 4A.10 (2011) (0)
- Letter to the Editor: RE: Impaired Cardiac Baroreflex Sensitivity Predicts Responses to Renal Sympathetic Denervation in Patients with Resistant Hypertension (2014) (0)
- Simultaneous characterization of sympathetic and cardiac arms of the baroreflex during incremental head-up tilt (2017) (0)
- Hypotensive Effects of Ganaxolone are Associated with an Upregulation of GABAA Receptor Subunit Expression in Male Hypertensive Schlager Mice (2020) (0)
- The effects of low dose clonidine on cardiac and renal sympathetic activity and brain monoamine turnover in human heart failure (2003) (0)
- RESTING CARDIAC PRODUCTION OF NATRIURETIC PEPTIDES DETERMINES THE HAEMODYNAMIC EFFECTS OF BRAIN NATRIURETIC PEPTIDE IN HEART FAILURE: 6C.4 (2000) (0)
- Renal sympathetic denervation for resistant hypertension – Authors' reply (2009) (0)
- The Effect of Renal Nerve Ablation on Blood Pressure and Sympathetic Activity One Year Post Procedure (2013) (0)
- 1 st Joint Meeting of the International Society for Autonomic Neuroscience and the American Autonomic Society (2011) (0)
- Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension (2023) (0)
- Wednesday, May 19, Broadway Ballroom North, 10:00 AM to 12:30 PM: “I1, imidazoline receptors: Clinical relevance in hypertensive patients” (1999) (0)
- European Society of Hypertens ion Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions (2009) (0)
- [OP.7A.08] A POLYMORPHISM IN THE NORADRENALINE TRANSPORTER GENE IS ASSOCIATED WITH INCREASED BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION (2017) (0)
- norepinephrineof voluntary exercise on hypothalamic (2015) (0)
- BETA1 (ARG389GLY, SER49GLY)- AND BETA2 (ARG16GLY)-ADRENOCEPTOR POLYMORPHISMS ARE RELATED TO LEFT VENTRICULAR HYPERTROPHY USING ECG IN MIDDLE-AGED, NORMOTENSIVE SUBJECTS: PP.22.358 (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Murray David Esler?
Murray David Esler is affiliated with the following schools: